Our data reveal an miRNA-dependent regulatory axis that links the well-known tumor suppressor miR-124 to IL-11-induced osteolysis, which when disrupted in breast cancer might be associated with bone metastasis development and subsequently a poor prognosis. The gene discussed is IL11; the disease is neoplasm.